UK markets close in 6 hours 27 minutes

ProKidney Corp. (PROK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.3000+0.1800 (+8.49%)
At close: 04:00PM EDT
2.3015 +0.00 (+0.07%)
After hours: 07:45PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 141.73M
Enterprise value -216.81M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)91.32
Enterprise value/revenue N/A
Enterprise value/EBITDA 1.73

Trading information

Stock price history

Beta (5Y monthly) 1.29
52-week change 3-75.94%
S&P500 52-week change 324.19%
52-week high 313.5100
52-week low 31.1200
50-day moving average 31.7410
200-day moving average 33.9001

Share statistics

Avg vol (3-month) 3742.25k
Avg vol (10-day) 31.48M
Shares outstanding 561.62M
Implied shares outstanding 6173.38M
Float 844.25M
% held by insiders 122.95%
% held by institutions 160.72%
Shares short (15 Apr 2024) 411.56M
Short ratio (15 Apr 2024) 418.53
Short % of float (15 Apr 2024) 418.84%
Short % of shares outstanding (15 Apr 2024) 418.76%
Shares short (prior month 15 Mar 2024) 414.61M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-20.18%
Return on equity (ttm)-30.22%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -147.67M
Net income avi to common (ttm)-35.47M
Diluted EPS (ttm)-0.5700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)362.95M
Total cash per share (mrq)5.89
Total debt (mrq)4.41M
Total debt/equity (mrq)1.13%
Current ratio (mrq)14.94
Book value per share (mrq)-18.43

Cash flow statement

Operating cash flow (ttm)-90.07M
Levered free cash flow (ttm)-77.08M